Evidence map›Paper›PMID 26933841›Full record

ArticleThe Pediatric infectious disease journal2016

The Effect of Deworming on Tests of Tuberculosis Infection in Children With Recent Tuberculosis Exposure: A Randomized Controlled Trial.

Marieke M Van der Zalm, Nelda van Soelen, Anna M Mandalakas, Marc Jacobsen, Anne K Detjen, Florian M Marx, Harleen M S Grewal, Mark F Cotton, Gerhard Walzl, Anneke C Hesseling

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in The Pediatric infectious disease journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Cytokine Responses duringMicroorganisms · 2023
    Article
  3. Article
  4. Article
  5. Tuberculosis susceptibility and protection in children.The Lancet. Infectious diseases · 2019
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Marieke M Van der ZalmFrom the *Faculty of Medicine and Health Sciences, Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Stellenbosch University, Stellenbosch, South Africa; †Section on Global and Immigration Health, Department of Pediatrics, Baylor College of Medicine, Houston, Texas; ‡Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Duesseldorf, Germany; §The International Union Against Tuberculosis and Lung Disease, Paris, France; ¶Department of Pediatric Pneumology and Immunology, Charité-Universitätsmedizin, Berlin, Germany; ‖Division of Global Health Equity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; **Faculty of Medicine and Dentistry, Department of Clinical Science, University of Bergen, Bergen, Norway; ††Department of Microbiology, Haukeland University Hospital, Bergen, Norway; ‡‡FAM-CRU, Faculty of Medicine and Health Sciences, Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa; and §§Immunology Research Group, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for TB Research, Faculty of Medicine and Health Sciences, Division of Molecular Biology and Human Genetics, Stellenbosch University, Stellenbosch, South Africa.
Nelda van Soelen
Anna M Mandalakas
Marc Jacobsen
Anne K Detjen
Florian M Marx
Harleen M S Grewal
Mark F Cotton
Gerhard Walzl
Anneke C Hesseling
Heinrich Heine University Düsseldorf · DEInternational Union Against Tuberculosis and Lung Disease · FRStellenbosch University · ZAUniversity of Bergen · NO

Funding

Stellenbosch University Clinical Trial Unit, Cape Town, South AfricaUM1AI069521 · NIAID · STELLENBOSCH UNIVERSITY · PI Shaun Barnabas, Anneke Catharina Hesseling · 2012 to 2026
$21.5M
The Utility of Interferon-Gamma Release Assays in TB-HIV co-infected ChildrenR01AI076199 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MANDALAKAS, ANNA M · 2007 to 2011
$2.7M
NIAID NIH HHS R01 AI076199NIAID NIH HHS UM1 AI069521
6 · The paper itself

Abstract

backgroundHelminth infestations are associated with T-helper cell type 2 (Th2) immune responses, leading to suppression of Th1 responses required to control Mycobacterium tuberculosis infection. We hypothesized that deworming after documented M. tuberculosis exposure might improve Th1 immune responses.

methodsThis was a randomized controlled trial comparing the effect of early versus delayed (after 3 months) deworming on tuberculin skin testing (TST) and Quantiferon-Gold-in-tube responses among children from a setting with a known high burden of M. tuberculosis and helminth co-infection in Cape Town, South Africa. Children aged 6 to 15 years with documented M. tuberculosis exposure were enrolled. Ascaris lumbricoides status was measured by Ascaris-specific IgE and stool microscopy.

resultsA total of 250 children (mean age, 9.6 years) were enrolled; 11.9% (27/227) were Ascaris stool microscopy positive and 54.2% (135/249) were Ascaris stool and/or IgE positive (Ascaris status). In univariable analysis, deworming at enrollment was not associated with a negative TST at 3 months (odds ratio, 0.61; 95% confidence interval, 0.35-1.07; P = 0.08). In stratified analysis, children with a positive Ascaris status were more likely to be TST negative at 3 months if dewormed early (odds ratio, 0.49; 95% confidence interval, 0.23-1.04; P = 0.06). In multivariable analysis, deworming was not associated with TST status (adjusted odds ratios, 0.62; 95% confidence interval, 0.34-1.10; P = 0.10). There was no association between deworming and Quantiferon-Gold-in-tube status.

conclusionsDeworming in children with recent M. tuberculosis exposure is associated with a trend toward a negative TST result. Timing of deworming might influence interpretation of TST in settings with high burdens of tuberculosis and helminths.

Indexed as

AdolescentAnimalsAnthelminticsAntibodies, HelminthAscariasisAscaris lumbricoidesChildDiagnostic Tests, RoutineFecesFemaleHumansImmunoglobulin EInterferon-gamma Release TestsMaleMicroscopyRandomized Controlled Trials as TopicAnthelminticsAntibodies, HelminthImmunoglobulin E

Identifiers

PMID26933841
PMCPMC11980818
OpenAlexW2335124289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.